Heterogeneous SARS-CoV-2 humoral response ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population.
Auteur(s) :
Carrat, Fabrice [Auteur]
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
Villarroel, Paola Mariela Saba [Auteur]
Unité des Virus Emergents [UVE]
Lapidus, Nathanael [Auteur]
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
Fourié, Toscane [Auteur]
Unité des Virus Emergents [UVE]
Blanché, Hélène [Auteur]
Centre d'Etude du Polymorphisme Humain [CEPH]
Dorival, Céline [Auteur]
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
Nicol, Jérôme [Auteur]
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
Deleuze, Jean‑François [Auteur]
Fondation Jean Dausset - Centre d’Etudes du Polymorphisme Humain [Paris] [CEPH]
Robineau, Olivier [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
Villarroel, Paola Mariela Saba [Auteur]
Unité des Virus Emergents [UVE]
Lapidus, Nathanael [Auteur]
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
Fourié, Toscane [Auteur]
Unité des Virus Emergents [UVE]
Blanché, Hélène [Auteur]
Centre d'Etude du Polymorphisme Humain [CEPH]
Dorival, Céline [Auteur]
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
Nicol, Jérôme [Auteur]
Institut Pierre Louis d'Epidémiologie et de Santé Publique [iPLESP]
Deleuze, Jean‑François [Auteur]
Fondation Jean Dausset - Centre d’Etudes du Polymorphisme Humain [Paris] [CEPH]
Robineau, Olivier [Auteur]

METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Titre de la revue :
Scientific Reports
Nom court de la revue :
Sci Rep
Numéro :
12
Pagination :
8622
Date de publication :
2022-05-26
ISSN :
2045-2322
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Assessment of the intensity, dynamics and determinants of the antibody response after SARS-CoV-2 infection or vaccination in the general population is critical to guide vaccination policies. This study characterized the ...
Lire la suite >Assessment of the intensity, dynamics and determinants of the antibody response after SARS-CoV-2 infection or vaccination in the general population is critical to guide vaccination policies. This study characterized the anti-spike IgG titers in 13,971 participants included in a French multicohort population-based serological survey on COVID-19 between April and October 2020 and followed-up with serological testing between May and October 2021. Eight follow-up profiles were defined depending on SARS-CoV-2 infection (0, 1 or 2) and COVID-19 vaccination (0, 1, 2 or 3). The anti-spike titer was lower in adults with no vaccination even in case of infection or reinfection, while it was higher in adults with infection followed by vaccination. The anti-spike titer was negatively correlated with age in vaccinated but uninfected adults, whereas it was positively correlated with age in unvaccinated but infected adults. In adults with 2 vaccine injections and no infection, the vaccine protocol, age, gender, and time since the last vaccine injection were independently associated with the anti-spike titer. The decrease in anti-spike titer was much more rapid in vaccinated than in infected subjects. These results highlight the strong heterogeneity of the antibody response against SARS-CoV-2 in the general population depending on previous infection and vaccination.Lire moins >
Lire la suite >Assessment of the intensity, dynamics and determinants of the antibody response after SARS-CoV-2 infection or vaccination in the general population is critical to guide vaccination policies. This study characterized the anti-spike IgG titers in 13,971 participants included in a French multicohort population-based serological survey on COVID-19 between April and October 2020 and followed-up with serological testing between May and October 2021. Eight follow-up profiles were defined depending on SARS-CoV-2 infection (0, 1 or 2) and COVID-19 vaccination (0, 1, 2 or 3). The anti-spike titer was lower in adults with no vaccination even in case of infection or reinfection, while it was higher in adults with infection followed by vaccination. The anti-spike titer was negatively correlated with age in vaccinated but uninfected adults, whereas it was positively correlated with age in unvaccinated but infected adults. In adults with 2 vaccine injections and no infection, the vaccine protocol, age, gender, and time since the last vaccine injection were independently associated with the anti-spike titer. The decrease in anti-spike titer was much more rapid in vaccinated than in infected subjects. These results highlight the strong heterogeneity of the antibody response against SARS-CoV-2 in the general population depending on previous infection and vaccination.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
CHU Lille
CHU Lille
Date de dépôt :
2023-11-15T04:08:22Z
2023-12-08T10:25:13Z
2023-12-08T10:25:13Z
Fichiers
- s41598-022-11787-4.pdf
- Non spécifié
- Accès libre
- Accéder au document